| Tretinoin | Approved Investigational Nutraceutical | GATA6 | 2627 |
upregulated | Tretinoin results in increased expression of GATA6 mRNA | 18q11.2 | |
| Tretinoin | Approved Investigational Nutraceutical | GATB | 5188 |
upregulated | Tretinoin results in increased expression of GATB mRNA | 4q31.3 | |
| Tretinoin | Approved Investigational Nutraceutical | GATC | 283459 |
downregulated | Tretinoin results in decreased expression of GATC mRNA | 12q24.31 | |
| Tretinoin | Approved Investigational Nutraceutical | GBA | 2629 |
downregulated | Tretinoin metabolite results in decreased expression of GBA mRNA | 1q22 | |
| Tretinoin | Approved Investigational Nutraceutical | GBF1 | 8729 |
downregulated | Tretinoin results in decreased expression of GBF1 mRNA | 10q24.32 | |
| Tretinoin | Approved Investigational Nutraceutical | GBP1 | 2633 |
upregulated | Tretinoin results in increased expression of GBP1 mRNA | 1p22.2 | |
| Tretinoin | Approved Investigational Nutraceutical | GBP2 | 2634 |
upregulated | Tretinoin results in increased expression of GBP2 mRNA | 1p22.2 | |
| Tretinoin | Approved Investigational Nutraceutical | GBP3 | 2635 |
upregulated | Tretinoin results in increased expression of GBP3 mRNA | 1p22.2 | |
| Tretinoin | Approved Investigational Nutraceutical | GBP4 | 115361 |
upregulated | Tretinoin results in increased expression of GBP4 mRNA | 1p22.2 | |
| Tretinoin | Approved Investigational Nutraceutical | GC | 2638 |
upregulated | Tretinoin results in increased expression of GC mRNA | 4q13.3 | |
| Tretinoin | Approved Investigational Nutraceutical | GCA | 25801 |
upregulated | Tretinoin results in increased expression of GCA mRNA | 2q24.2 | |
| Tretinoin | Approved Investigational Nutraceutical | GCAT | 23464 |
downregulated | Tretinoin results in decreased expression of GCAT mRNA | 22q13.1 | |
| Tretinoin | Approved Investigational Nutraceutical | GCC2 | 9648 |
upregulated | Tretinoin results in increased expression of GCC2 mRNA | 2q12.3 | |
| Tretinoin | Approved Investigational Nutraceutical | GCH1 | 2643 |
upregulated | Tretinoin results in increased expression of GCH1 mRNA | 14q22.2 | |
| Tretinoin | Approved Investigational Nutraceutical | GCHFR | 2644 |
upregulated | Tretinoin results in increased expression of GCHFR mRNA | 15q15.1 | |
| Tretinoin | Approved Investigational Nutraceutical | GDAP1 | 54332 |
downregulated | Tretinoin results in decreased expression of GDAP1 mRNA | 8q21.11 | |
| Tretinoin | Approved Investigational Nutraceutical | GDF10 | 2662 |
upregulated | Tretinoin results in increased expression of GDF10 mRNA | 10q11.22 | |
| Tretinoin | Approved Investigational Nutraceutical | GDF11 | 10220 |
upregulated | Tretinoin results in increased expression of GDF11 mRNA | 12q13.2 | |
| Tretinoin | Approved Investigational Nutraceutical | GDF15 | 9518 |
upregulated | Tretinoin metabolite results in increased expression of GDF15 mRNA | 19p13.11 | |
| Tretinoin | Approved Investigational Nutraceutical | GDF15 | 9518 |
downregulated | Tretinoin results in decreased expression of GDF15 mRNA | 19p13.11 | |
| Tretinoin | Approved Investigational Nutraceutical | GDF15 | 9518 |
upregulated | Tretinoin results in increased expression of GDF15 mRNA | 19p13.11 | |
| Tretinoin | Approved Investigational Nutraceutical | GDF2 | 2658 |
downregulated | Tretinoin metabolite results in decreased expression of GDF2 mRNA | 10q11.22 | |
| Tretinoin | Approved Investigational Nutraceutical | GDF2 | 2658 |
downregulated | Tretinoin results in decreased expression of GDF2 mRNA | 10q11.22 | |
| Tretinoin | Approved Investigational Nutraceutical | GDF3 | 9573 |
downregulated | Tretinoin results in decreased expression of GDF3 mRNA | 12p13.31 | |
| Tretinoin | Approved Investigational Nutraceutical | GDPD5 | 81544 |
downregulated | Tretinoin results in decreased expression of GDPD5 mRNA | 11q13.4-q13.5 | |